RavenQuest Acquires Licensed Producer in Ontario
February 1st, 2018
Exclusive, News, Top News
Canada’s cannabis industry has become one of the largest and most mature markets in the world, as the only G20 country to have legalized both medical and recreational marijuana. While investors have many different opportunities in the space, they may want to focus on diversified companies that have near-term revenue and long-term intellectual property potential. This helps deliver value now and diversify against the risk of commoditization in the future.
RavenQuest BioMed Inc. (CSE: RQB) has taken a Four Pillar approach to the market that involves working with indigenous populations, building out its own production, providing management services, and conducting research and development. And, a new letter of intent with an existing licensed producer could help accelerate all of these initiatives in the near-term.
Rapidly Expanding Market
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis later this year. Despite nearly 90 licensed producers, PI Financial anticipates a 187,885 kilogram shortfall in production by 2019. This creates a unique opportunity for licensed producers to ramp up production over the coming years to capitalize on the significant demand.
Licensed producers may be the most obvious way to capitalize on the market, but there are many other companies to consider in the space. Several companies are developing innovative growing and extraction technologies designed to help produce cannabis oils and enhance yields; biotech companies are developing innovative next-generation medicines; and, consulting firms are helping provide the support to grow the industry.
RavenQuest BioMed is a unique opportunity that takes advantage of many parts of the industry. In addition to its cultivation efforts, the company is engaged in research and development aimed at maximizing a metric that it feels is most relevant – grams per square foot. Its unique technologies have already demonstrated strong potential, while its consulting division is aimed at helping aspiring licensed producers get up and running.
RavenQuest’s New Acquisition
RavenQuest BioMed recently announced a binding letter of intent to acquire Bloomera, a licensed producer of medical cannabis in Ontario with a 2,000 kilograms per year capacity. Under the terms of the letter of intent, the company will acquire all of the outstanding shares of Bloomera in consideration for a cash payment of $15 million and the issuance of 10.4 million common shares of stock to existing Bloomera shareholders.
“The Bloomera acquisition accelerates our growth strategy by at least six months and opens the door to a much faster growth trajectory as we move forward,” said RavenQuest CEO George Robinson. “Markham, Ontario provides low cost access to the upcoming retail distribution network and the municipality has a large skilled workforce available … The addition of Bloomera provides us with direct access to the Greater Toronto Area – Canada’s largest cannabis market.”
In addition to Bloomera, the company owns Alberta Green Biotech, an Edmonton, Alberta-based facility with expected annual production of approximately 7,000 kilograms per year by mid-summer 2018 after it obtains approval from Health Canada. Management expects to increase annual production from the two facilities to 11,000 kilograms per year using its yield-maximization research developed in partnership with McGill.
RavenQuest BioMed Inc. (CSE: RQB) has a market capitalization of less than C$100 million despite its significant potential as a licensed producer, unique focus on indigenous populations, and its growing portfolio of growing technologies. With the potential acquisition of an existing licensed producer, the company will jumpstart its plans by immediately moving into production and implementing its yield-maximization technologies to prove their benefit.
For more information, visit the company’s website at www.rqbglobal.com.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please see our disclaimer below and follow the link to view our full disclosure outlining compensation: https://www.cannabisfn.com/legal-disclaimer/
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.